Ecolab (NYSE:ECL) Rating Increased to Outperform at Oppenheimer
π Oppenheimer upgraded Ecolab to Outperform with a $320 price target following strong quarterly results.
π UBS raised its rating to Buy and lifted the price target to $325, while Citigroup increased its objective to $330.
π° Ecolab reported Q1 2026 EPS of $1.70, matching consensus estimates on revenue of $4.07 billion.
π Revenue grew 10% year-over-year, driven by growth in hospitality, foodservice, and healthcare sectors.
πΉ The company achieved a 22.64% return on equity and maintained a healthy 12.80% net margin.
π Management set FY 2026 EPS guidance between $8.43 and $8.63, exceeding analyst consensus of $8.13.
πΈ A quarterly dividend of $0.73 was paid on July 15th with an annualized yield of 1.1%.
π¦ Institutional ownership stands at 74.91%, with Vanguard and JPMorgan Chase increasing holdings in Q4.
π COO Darrell Brown sold shares, while EVP Benjamin Clark purchased stock, resulting in net insider buying.
π Ecolab provides water, hygiene, and infection prevention solutions across global end markets.
- Oppenheimer upgraded the stock to Outperform with a $320 price target, aligning with recent upgrades from UBS and Citigroup.
- Q1 2026 earnings beat expectations with revenue of $4.07 billion representing a 10% year-over-year increase.
- The company delivered strong profitability metrics including a 22.64% return on equity and a 12.80% net margin.
- FY 2026 guidance of $8.43-$8.63 EPS exceeds the sell-side consensus estimate of $8.13.
- Major institutional investors like Vanguard and JPMorgan Chase increased their stakes in the fourth quarter.
- The company maintains a sustainable dividend yield of 1.1% with a payout ratio of 39.51%.
- COO Darrell Brown sold 10,000 shares worth $2.6 million, representing a 23.40% decrease in his personal ownership.
- Analyst consensus price target of $324.06 is slightly below Oppenheimer's new $320 target but reflects mixed short-term sentiment.